Agonists and antagonists of prolixin for the treatment of metabolic disorders
US7344843B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Oct 14, 2002 |
| Grant date | Mar 18, 2008 |
| Priority date | — |
| Expiry date | Dec 17, 2023 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/044
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to the field of metabolic research, in particular the discovery of compounds effective for reducing body mass and useful for treating obesity-related diseases and disorders. The obesity-related diseases or disorders envisioned to be treated by the methods of the invention include, but are not limited to, hyperlipidemia, atherosclerosis, insulin resistance, diabetes, and hypertension. In particular, the invention provides for methods of identifying and using AGONISTS and ANTAGONISTS of PROLIXIN activity, wherein said activity is selected from the group consisting of lipid partitioning, lipid metabolism, and insulin-like activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.